Cargando…

Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)

Breast cancer (BC) is the most commonly diagnosed malignant disease and the leading cause of cancer death in women in Austria. We investigated overall and subgroup-specific female breast cancer rates to provide a comprehensive analysis of trends over several decades. Incidence, mortality, and surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilic, Lazo, Haidinger, Gerald, Simon, Judit, Hackl, Monika, Schernhammer, Eva, Papantoniou, Kyriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054853/
https://www.ncbi.nlm.nih.gov/pubmed/35487918
http://dx.doi.org/10.1038/s41598-022-10560-x
_version_ 1784697285131632640
author Ilic, Lazo
Haidinger, Gerald
Simon, Judit
Hackl, Monika
Schernhammer, Eva
Papantoniou, Kyriaki
author_facet Ilic, Lazo
Haidinger, Gerald
Simon, Judit
Hackl, Monika
Schernhammer, Eva
Papantoniou, Kyriaki
author_sort Ilic, Lazo
collection PubMed
description Breast cancer (BC) is the most commonly diagnosed malignant disease and the leading cause of cancer death in women in Austria. We investigated overall and subgroup-specific female breast cancer rates to provide a comprehensive analysis of trends over several decades. Incidence, mortality, and survival, as well as age-, stage-, and birth cohort-specific incidence were analysed using nationwide cancer registry data on 163,694 cases of female breast cancer in Austria (1983–2017). Annual percentage changes were estimated using joinpoint regression. BC incidence underwent linear increases until 1997 and reversed with statistically non-significant declines until 2017. After initial increases in BC-specific mortality, rates were stable from 1989 through 1995 and started declining thereafter, although statistically non-significantly after 2011. Overall BC-specific survivals, as well as survivals according to the calendar period of diagnosis, increased throughout the observation period. Incidence in younger women (aged 44 and lower) showed linear increases, whereas for women aged 45 and higher mostly stable or decreasing rates were observed. Localised BC incidence increased markedly and started declining only in 2012. Distant disease-BC incidence decreased through the whole observation period and incidence of regionalised BC started declining in 2000. Birth cohort-specific incidence peaked in women born between 1935 and 1949 (ages 45–74). In conclusion, the incidence of BC in younger women is increasing, while overall female BC incidence and mortality are stable with non-significant declines. Further, increases in the incidence of early-stage BC (localised) seem disproportionately high in comparison to more modest decreases in late-stage BC incidence (regionalised and distant disease).
format Online
Article
Text
id pubmed-9054853
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90548532022-05-01 Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017) Ilic, Lazo Haidinger, Gerald Simon, Judit Hackl, Monika Schernhammer, Eva Papantoniou, Kyriaki Sci Rep Article Breast cancer (BC) is the most commonly diagnosed malignant disease and the leading cause of cancer death in women in Austria. We investigated overall and subgroup-specific female breast cancer rates to provide a comprehensive analysis of trends over several decades. Incidence, mortality, and survival, as well as age-, stage-, and birth cohort-specific incidence were analysed using nationwide cancer registry data on 163,694 cases of female breast cancer in Austria (1983–2017). Annual percentage changes were estimated using joinpoint regression. BC incidence underwent linear increases until 1997 and reversed with statistically non-significant declines until 2017. After initial increases in BC-specific mortality, rates were stable from 1989 through 1995 and started declining thereafter, although statistically non-significantly after 2011. Overall BC-specific survivals, as well as survivals according to the calendar period of diagnosis, increased throughout the observation period. Incidence in younger women (aged 44 and lower) showed linear increases, whereas for women aged 45 and higher mostly stable or decreasing rates were observed. Localised BC incidence increased markedly and started declining only in 2012. Distant disease-BC incidence decreased through the whole observation period and incidence of regionalised BC started declining in 2000. Birth cohort-specific incidence peaked in women born between 1935 and 1949 (ages 45–74). In conclusion, the incidence of BC in younger women is increasing, while overall female BC incidence and mortality are stable with non-significant declines. Further, increases in the incidence of early-stage BC (localised) seem disproportionately high in comparison to more modest decreases in late-stage BC incidence (regionalised and distant disease). Nature Publishing Group UK 2022-04-29 /pmc/articles/PMC9054853/ /pubmed/35487918 http://dx.doi.org/10.1038/s41598-022-10560-x Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ilic, Lazo
Haidinger, Gerald
Simon, Judit
Hackl, Monika
Schernhammer, Eva
Papantoniou, Kyriaki
Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)
title Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)
title_full Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)
title_fullStr Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)
title_full_unstemmed Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)
title_short Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)
title_sort trends in female breast cancer incidence, mortality, and survival in austria, with focus on age, stage, and birth cohorts (1983–2017)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054853/
https://www.ncbi.nlm.nih.gov/pubmed/35487918
http://dx.doi.org/10.1038/s41598-022-10560-x
work_keys_str_mv AT iliclazo trendsinfemalebreastcancerincidencemortalityandsurvivalinaustriawithfocusonagestageandbirthcohorts19832017
AT haidingergerald trendsinfemalebreastcancerincidencemortalityandsurvivalinaustriawithfocusonagestageandbirthcohorts19832017
AT simonjudit trendsinfemalebreastcancerincidencemortalityandsurvivalinaustriawithfocusonagestageandbirthcohorts19832017
AT hacklmonika trendsinfemalebreastcancerincidencemortalityandsurvivalinaustriawithfocusonagestageandbirthcohorts19832017
AT schernhammereva trendsinfemalebreastcancerincidencemortalityandsurvivalinaustriawithfocusonagestageandbirthcohorts19832017
AT papantonioukyriaki trendsinfemalebreastcancerincidencemortalityandsurvivalinaustriawithfocusonagestageandbirthcohorts19832017